Physician profile
Hatem Mourad
NPI 1730220070
$954.02
in general payments reported to CMS, 2019-2025
18 companies · $64.14 in 2025
The $64.14 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $75.17 · 2021: $96.16 · 2022: $107 · 2023: $57.34 · 2024: $432 · 2025: $64.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $553.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $158.03 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.54 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $127.74 | 2019-2022 | |
| Inspire Medical Systems, INC. | $125.00 | 2024 | Inspire |
| Abiomed | $81.04 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $46.70 | 2021-2024 | Fasenra |
| Merck Sharp & Dohme LLC | $37.18 | 2024-2025 | Zerbaxa, Dificid |
| Ambu INC. | $36.33 | 2025 | |
| Novartis Pharmaceuticals Corporation | $31.07 | 2019-2020 | |
| Allergan, INC. | $23.55 | 2019 | |
| Alexion Pharmaceuticals, INC. | $23.20 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.15 | 2020 | |
| Vifor Pharma, INC. | $17.63 | 2022 | |
| Bioxcel Therapeutics, INC. | $16.74 | 2023 | Igalmi |
| Boston Scientific Corporation | $16.67 | 2024 | Watchman Access System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.14 | 2021 | |
| Pfizer INC. | $11.68 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9.63 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hatem Mourad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.